CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The diaRNAgnosis project aims to develop the ODG Platform for the direct and accurate measurement of circulating cell-free ribonucleic acids (ccfRNAs) to identify cancer biomarkers. This innovative technology targets specific cancer types, such as testicular germ cell tumors and prostate cancer, enhancing diagnostic ca…
Circulating cell-free ribonucleic acids (ccfRNAs) represent an emerging and important class of molecules, able to provide significant clinical relevance as novel screening, prognostic and therapy monitoring biomarkers in cancer.
Through analysing specific ccfRNAs, different cancers can be accurately correlated for type and stage.
Sadly, despite extensive academic and clinical research identifying and validating in limited clinical trials, ccfRNAs have not yet entered the field of clinical diagno…
DESTINA GENOMICA SLNE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Trento
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Italy, Catania
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Trento
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
